Navigation Links
MAQUET Medical Systems USA Launches The MIRA-i CS Retractor System For Use During Minimally Invasive Revascularization Procedures
Date:3/26/2013

WAYNE, N.J., March 26, 2013 /PRNewswire/ -- MAQUET Medical Systems USA and MAQUET Cardiovascular today announced the launch of the MIRA-i CS Retractor System, an innovative, modular system designed to provide unsurpassed cardiothoracic access during minimally invasive revascularization procedures. The MIRA-i CS Retractor features a unique, pivoting mechanism that maximizes access and visibility through the smallest of incisions, thus avoiding the need for a sternotomy with its associated risks and complications.

"The MIRA-i CS Retractor is an important addition to our cardiac surgery offering that may allow physicians to improve their practice and help patients quickly return to their normal daily routine," said Raoul Quintero , president and chief executive officer of MAQUET Medical Systems USA. "The use of the MIRA-i CS Retractor during revascularization procedures may reduce post-operative discomfort and lead to a shorter recovery process, faster healing, fewer infections and less scarring for patients."

The MIRA-i CS Retractor offers both titanium internal mammary artery (IMA) blades, which attach to any table-based retractor system providing lift for easy access to this artery, as well as aluminum thoracotomy blades—all of which are radiolucent, making them compatible with diagnostic imaging during hybrid PCI-CABG procedures. The MIRA-i CS Retractor unique pivot mechanism allows the blades to deflect up to 30 degrees, increasing visibility and instrument maneuverability, without the need to increase the incision length. Furthermore, the interchangeable blades attach to retractor arms that are hinged, which minimizes workplace interference and improves the ergonomic experience for the surgeon.

"This product, similar to others in our cardiac surgery portfolio, provides physicians additional options to perform high-quality, minimally invasive procedures on patients," said Christian Keller , president and chief executive officer of MAQUET Cardiovascular. "Our technical advancements in minimally invasive cardiac surgery continue to offer solutions to physicians that may improve patient recovery and enhance quality of life."   

About MAQUET

MAQUET, a trusted partner for hospitals and physicians for over 175 years, is the global leader in providing medical systems that meet the needs of the most medically challenging patients, while exceeding the expectations of the hospital teams that care for them. MAQUET designs, develops and distributes innovative therapy solutions and infrastructure capabilities for high-acuity areas within the hospital including the operating room (OR), hybrid OR/cath lab and intensive care unit (ICU) as well as intra and inter hospital patient transport.

Headquartered in Rastatt, Germany, MAQUET is the largest subsidiary of the publicly listed Getinge Group AB of Sweden. MAQUET generated nearly 1.4 billion Euros in 2011, representing more than half of the Getinge Group's annual revenue of 2.4 billion Euros. MAQUET has 6,000 employees in 50 international sales and service organizations, as well as a network of more than 280 sales representatives. For more information please visit www.maquet.com

MAQUET – The Gold Standard

www.maquet.com

www.getinge.com


'/>"/>
SOURCE MAQUET Medical Systems USA
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. MAQUET Cardiovascular Announces U.S. Food and Drug Administration Panel Votes To Reclassify Intra-Aortic Balloon Pumps To A Class II Designation In Certain Indications
2. MAQUET Cardiovascular Announces Results Of The IABP-SHOCK II Trial Of Intra-aortic Balloon Counterpulsation Therapy In Cardiogenic Shock Patients
3. MAQUET Initiates Class I Recall of the FLOW-i Anesthesia System
4. MAQUET Cardiovascular Receives FDA 510(k) Clearance For New Mega® Intra-Aortic Balloon Catheter Sizes
5. Medical Supply Company Joy Comfort LLC Launches New E-Commerce Website
6. KIMES 2013, Biggest Medical Exhibition Show in Asia!
7. RoundTable Healthcare Partners and Argon Medical Devices to Acquire Angiotech Pharmaceuticals Interventional Products Business
8. Vasomedical to Report Fourth Quarter and Year End 2012 Results on April 1, 2013
9. Cantel Medicals Mar Cor Purification Subsidiary Acquires Hemodialysis Water Business from Siemens Water Technologies Business Unit
10. Creative Edge Nutrition, Inc. Announces the Entrance into the Medical Marijuana Sector
11. Innovative Danish Project Sets new Standards for Medical Imaging
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... -- The Academy of Managed Care Pharmacy (AMCP) today ... allow biopharmaceutical companies to more easily share health care ... coverage decisions, a move that addresses the growing need ... The recommendations address restrictions in the sharing of product ... a prohibition that hinders decision makers from accessing HCEI ...
(Date:6/24/2016)... June 24, 2016 According to ... Type (Standard Pen Needles, Safety Pen Needles), Needle Length ... Growth Hormone), Mode of Purchase (Retail, Non-Retail) - Trends ... report studies the market for the forecast period of ... USD 2.81 Billion by 2021 from USD 1.65 Billion ...
(Date:6/23/2016)... HOUSTON , June 23, 2016  MedSource ... platform as its e-clinical software solution of choice.  ... the best possible value to their clients by ... nowEDC.  The preferred relationship establishes nowEDC as the ... pricing for MedSource,s full-service clients.  "nowEDC has long ...
Breaking Medicine Technology:
(Date:6/25/2016)... FL (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton Memorial ... Plant City Observer , brings up a new, often overlooked aspect of head lice: the ... closing for fumigation is not a common occurrence, but a necessary one in the event ...
(Date:6/25/2016)... ... ... First Choice Emergency Room , the largest network of independent freestanding ... of its new Mesquite-Samuell Farm facility. , “We are pleased to announce Dr. ... James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , Dr. ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
(Date:6/25/2016)... ... ... Conventional wisdom preaches the benefits of moderation, whether it’s a matter of indulgence ... high can result in disappointment, perhaps even self-loathing. However, those who set the bar ... from PsychTests.com reveals that behind the tendency to set low expectations is ...
(Date:6/24/2016)... Marne, Michigan (PRWEB) , ... June 24, 2016 , ... ... To deal with these feelings, many turn to unhealthy avenues, such as drug or ... Center of Marne, Michigan, has released tools for healthy coping following a traumatic event. ...
Breaking Medicine News(10 mins):